Risk factors and survival in patients with COVID-19 in northeastern Brazil
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Knowledge about the epidemiology and risk factors surrounding COVID-19 contributes to developing better health strategies to combat the disease.
Objective
This study aimed to establish a survival analysis and identify the risk factors for patients with COVID-19 in an upper middle-income city in Brazil.
Methods
A retrospective cohort study was conducted with 280 hospitalized patients with COVID-19. The eCOVID platform provided data to monitor COVID-19 cases and help the communication between professionals.
Results
Age ≥ 65 years was associated with decreased survival (54.8%), and females had a lower survival rate than males (p = 0.01). Regarding risk factors, urea concentration (p<0.001), hospital length of stay (p = 0.002), oxygen concentration (p = 0.005), and age (p = 0.02) were associated with death.
Conclusion
Age, hospital length of stay, high blood urea concentration, and low oxygen concentration were associated with death by COVID-19 in the studied population. These findings corroborate with studies conducted in research centers worldwide.
Article activity feed
-
-
SciScore for 10.1101/2022.01.27.22269602: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study was approved by the local research ethics committee (approval number 4.241.971) and followed all ethical aspects involving research in humans and the Declaration of Helsinki. Sex as a biological variable We included hospitalized patients of both sexes, aged 18 or over, diagnosed with COVID-19 using RT-PCR test (nasopharynx swab)3, with epidemiological history of COVID-19 and/or relevant clinical symptoms and serological parameters9,10. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources The software Statistical Package for the Social Sciences version 22 (IBM Corp., Statistical Package for the Social …SciScore for 10.1101/2022.01.27.22269602: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study was approved by the local research ethics committee (approval number 4.241.971) and followed all ethical aspects involving research in humans and the Declaration of Helsinki. Sex as a biological variable We included hospitalized patients of both sexes, aged 18 or over, diagnosed with COVID-19 using RT-PCR test (nasopharynx swab)3, with epidemiological history of COVID-19 and/or relevant clinical symptoms and serological parameters9,10. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources The software Statistical Package for the Social Sciences version 22 (IBM Corp., Statistical Package for the Social Sciencessuggested: (SPSS, RRID:SCR_002865)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Limited access of the population to COVID-19 diagnostic test and its acquisition and availability by the health system may be a potential limitation of this study. Specifically during hospital care, some patients were already outside the window of time to detect SARS-CoV-2 using RT-PCR. Therefore, diagnosis was performed by identifying immunoglobulins M and G and clinical and/or radiological evolution of the patient. Furthermore, the unfamiliarity of the population with signs and symptoms of COVID-19 may have delayed healthcare seeking. As a result, patients arrived at the hospital with advanced disease.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-